This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FX4XC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,676.96 firm fixed-price delivery order is for the supply of 4566325055 - Lidocaine HCL 2% 100 mg/5 ml, 5 ml. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Generated 2/3/25, 1:08 PM